Quinn Maryanne, Ficociello Linda H, Rosner Bernard
Division of Endocrinology, Children's Hospital Boston, Boston, MA 02115, USA.
Pediatr Diabetes. 2003 Dec;4(4):162-7. doi: 10.1111/j.1399-543X.2003.00026.x.
To characterize the intraindividual relationships between changes in weight, glycosylated hemoglobin (HbA1c) levels, and reported total daily insulin dose between clinic visits in adolescent boys with type 1 diabetes (T1D).
Intraindividual changes in HbA1c, anthropometric data, and reported total daily insulin dose between consecutive visits for 94 adolescent boys with T1D were analyzed.
Average quarterly weight gain was 2.8 kg during periods of improving, 1.5 kg during periods of minimal change, and 0.8 kg during periods of worsening glycemic control (improving vs. minimal change p < 0.001; minimal change vs. worsening p = 0.11; improving vs. worsening p < 0.001). Analyzing the quarterly weight velocity according to change in reported total daily dose of insulin, we found significantly greater weight gain during intervals when the family reported a decreasing insulin dose compared to intervals when the family reported no change in insulin dose (p = 0.003). Conversely, weight change during periods of reported increasing insulin dose was similar to that when the family reported that the boy's insulin dose did not change.
Quarterly weight velocity was correlated with degree of change in glycemic control between visits in adolescent boys with T1D. When weight loss or inadequate weight gain and worsening glycemic control occur, the possibility of insulin omission must be explored. Reviewing the adolescent's growth data and then the division of responsibilities for diabetes management within the family, clinicians must reconcile discrepancies between weight velocity and a reportedly adequate dose of insulin.
描述1型糖尿病(T1D)青少年男性患者就诊期间体重变化、糖化血红蛋白(HbA1c)水平变化与每日胰岛素总剂量之间的个体内关系。
分析了94例T1D青少年男性患者连续就诊期间HbA1c、人体测量数据以及每日胰岛素总剂量的个体内变化。
血糖控制改善期间平均季度体重增加2.8千克,变化最小期间为1.5千克,血糖控制恶化期间为0.8千克(改善与变化最小相比,p<0.001;变化最小与恶化相比,p = 0.11;改善与恶化相比,p<0.001)。根据报告的每日胰岛素总剂量变化分析季度体重增长速度,我们发现,与家庭报告胰岛素剂量无变化的时间段相比,家庭报告胰岛素剂量减少的时间段体重增加明显更多(p = 0.003)。相反,报告胰岛素剂量增加期间的体重变化与家庭报告男孩胰岛素剂量未变化时相似。
T1D青少年男性患者就诊期间的季度体重增长速度与血糖控制变化程度相关。当出现体重减轻或体重增加不足以及血糖控制恶化时,必须探究胰岛素漏用的可能性。临床医生在查看青少年的生长数据以及家庭内糖尿病管理责任分工后,必须协调体重增长速度与据报道足够的胰岛素剂量之间的差异。